Change Management – From Insights Into Action
What does it take for a company to achieve change management on diversity and inclusion (D&I) efforts? What is the momentum needed within a company to take on D&I efforts? What tools and resources currently exist? How does one engage with the CEO and leadership on these efforts? These questions and more will be explored as you join experts who have tackled these challenges and will provide solutions that work towards change management best practices of D&I efforts, driving insights into action.What does it take for a company to achieve change management on diversity and inclusion (D&I) efforts? What is the momentum needed within a company to take on D&I efforts? What tools and resources currently exist? How does one engage with the CEO and leadership on these efforts? These questions and more will be explored as you join experts who have tackled these challenges and will provide solutions that work towards change management best practices of D&I efforts, driving insights into action.
Session Chair(s)
Dyan Bryson
Founder, Patient Engagement Strategist
Inspired Health Strategies, United States
Dyan Bryson is a patient engagement strategist and has forged the way for the patient engagement space since 2007. After spending 20+ years in traditional sales, sales leadership and marketing at Merck and Ciba-Geigy (now Novartis) Dyan has spent the last 15 years laser focused on patient engagement, patient advocacy, patient-centricity. Dyan makes the life sciences industry talk of being patient centered very real. In the last 2 years Dyan has used this patient centered lens to drive work in helping companies ensure diversity in clinical trials. She is currently working with ICON to support Janssen to develop and implement diversity in clinical trials efforts.
Speaker(s)
Anthony Yanni, MD, MBA
SVP, Patient Centricity
Astellas, United States
Jessica S. Scott, JD, MD
President
Legacy Health Strategies , United States
Jessica is a Patient Engagement leader who brings to Legacy Health Strategies a combined acumen of medicine and law, together with innovative thinking, to drive the culture change of increasing patient perspectives in medical product development to result in mutually beneficial outcomes for patients and industry. She is known as a credible and trusted thought-leader and collaborator, bringing novel solutions, digital strategies, and patient-centered approaches to biotech, med tech and pharmaceutical industries and across multi-stakeholder groups. She has deep knowledge of the pharmaceutical industry from leadership positions at GlaxoSmithKline and Takeda where she focused on building patient perspectives into the process of R&D.
Donna Schwarz
Founder
Schwarz Consultants, United States
Adam Brown
Founder and CEO
Clinark, United States
Adam is the Founder and Chief Executive Officer at ClinArk. The work at ClinArk is centered around empathy and bringing diverse perspectives together through community engagement with the goal of helping shape better trials. Most importantly, Adam is also a husband to an amazing wife and a dad to three awesome kids.
Danielle Mitchell
CEO and Founder
Black Women In Clinical Research, United States
Marya Shegog, MPH
Health Equity and Diversity Coordinator
The Lazarus Project, United States
Douglas Noland, MBA
Head of Patient Partnerships, Executive Director
Astellas, United States
I’ve worked in healthcare for the past 30 years, and Astellas for the last 15 years, in a variety of leadership roles from manufacturing to sales and marketing as well as strategy, change and innovation. The past several years at Astellas have enabled me to discover my real passion is for helping to create a meaningful and lasting impact through the creation and delivery of “even more” VALUE for the patients that we serve. As head of Patient Partnership's, me and my team have the opportunity to create authentic platforms for Astellas colleagues across our business to better understand and address what truly matters most to patients and their families.